Objectives: To characterize linezolid resistance among blood cultured Staphylococcus epidermidis from patients at the Polyclinic Agostino Gemelli (2006 -08). Isolates also showed elevated MICs of macrolide, lincosamide and streptogramin (MLS) compounds, which were investigated.
Introduction
Linezolid was the first member of the oxazolidinone class to be introduced into clinical practice. 1 Resistance surveillance programmes (2008 samples) have reported overall linezolid resistance rates of 0.4% in the USA, while rates as low as 0.1% have been described among Gram-positive isolates from non-USA medical sites. 2, 3 The vast majority of linezolid-resistant organisms detected in the nosocomial environment possess a G2576T mutation in domain V of 23S rRNA. 4 Other mutations, such as T2500A, G2447T and T2504A have also been reported. 5 Moreover, modifications in the conserved regions of ribosomal proteins L3 and L4 have been associated recently with elevated MICs of linezolid. 1, 4, 6 Initially associated with chloramphenicol resistance, Cfr represents an additional linezolid resistance mechanism identified in staphylococci. 7 Cfr causes post-transcriptional methylation of 23S ribosomal RNA at position A2503, which affects the binding of drugs belonging to at least five antimicrobial classes (phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A). 8 Initially detected among staphylococci recovered from animal specimens in Europe, 7 more recently, cfr has been reported in Staphylococcus spp. recovered from human clinical specimens in the USA, Colombia and Spain. 9 -11 Resistance to macrolide, lincosamide and streptogramin (MLS) compounds is usually caused by ribosomal modification, active efflux pumps or enzymatic inactivation. 12 Target site modifications, the most common mechanism, are due to ribose methylase genes (erm), and the encoded protein methylates the adenine residue A2058 in the 23S rRNA domain V. 13 This single alteration will cause the so-called MSL B resistance phenotype.
14 Efflux pump systems responsible for MLS resistance in staphylococci belong to two distinct families. The macrolide and streptogramin B resistance protein Msr(A) belongs to the ABC transporter families, which also include Vga(A) and Vga(B) variants. 15 These proteins exhibit structural similarities; however, Vga(A) and Vga(B) possess different drug specificities when compared with Msr(A). Vga(A) and Vga(B) variants have been reported to mediate decreased susceptibility or resistance to lincosamides, streptogramin A and/or pleuromutilins. 16, 17 Other members of the ABC transporter families, Lsa(A) and Lsa(B), have been reported to confer resistance to lincosamides and streptogramin A in Enterococcus faecalis and Staphylococcus sciuri. 13 The macrolide efflux protein [Mef(A)] belongs to the major facilitator family and encodes resistance for macrolides only.
14 MLS resistance due to enzymatic inactivation reported in staphylococci includes Vgb(A), Vgb(B), Lnu(A), Vat(A), Vat(B), Vat(C) and Mph(C). 18 During the time interval February 2006 -October 2007, nine Staphylococcus epidermidis recovered from blood specimens in hospitalized patients at the Polyclinic Agostino Gemelli (Rome, Italy) exhibited decreased susceptibility to linezolid (MIC, 4 and 8 mg/L). In May 2008, an additional S. epidermidis bloodcultured from a 57-year-old male patient, who underwent liver transplantation at the same facility, showed a linezolid MIC value of 64 mg/L. The main objective of this study was to characterize the linezolid resistance mechanisms among these 10 clinical isolates of S. epidermidis. Furthermore, as several isolates demonstrated elevated MICs of erythromycin (.2 mg/L), clindamycin (.64 mg/L) and quinupristin/dalfopristin (1 -2 mg/L), the resistance mechanisms for MLS compounds were also investigated.
Materials and methods

Clinical isolates
A total of 230 coagulase-negative staphylococci (CoNS) were collected from hospitalized patients at the Polyclinic Agostino Gemelli (Rome, Italy) during 2006-08. These CoNS isolates were submitted to a central monitoring laboratory (JMI Laboratories, North Liberty, IA, USA) as part of the SENTRY antimicrobial surveillance programme. Among these CoNS, 10 S. epidermidis recovered from blood cultures displayed elevated linezolid MIC values (4-64 mg/L; susceptible, ≤4 mg/L; resistant, ≥8 mg/L) and were included in this study to further investigate the oxazolidinone and MLS resistance mechanisms.
Antimicrobial susceptibility testing
Isolates were tested for susceptibility by the reference broth microdilution method using cation-adjusted Mueller-Hinton broth in validated panels (TREK Diagnostics Inc., Cleveland, OH, USA), according to CLSI methods. 19 Interpretation of MIC results was based on published CLSI and European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. 20, 21 Retapamulin MIC results were interpreted according to parameters reported by Traczewski and Brown. 22 Quality control (QC) strains were Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212. 20 Screening for ribosomal target site mutations and the cfr gene Screening for cfr and mutations in the central loop of the domain V region of 23S rRNA was performed as described previously. 9 Genes encoding the L3, L4 and L22 ribosomal proteins were PCR amplified using the primers described in Table 1 . Amplicons were sequenced on both strands, and nucleotide and deduced amino acid sequences were analysed using the Lasergene software package (DNASTAR, Madison, WI, USA). Amino acid sequences were compared with those obtained from a linezolidsusceptible (MIC, 1 mg/L) clinical S. epidermidis recovered from the same hospital during the study interval. In addition, ribosomal proteins from the S. epidermidis ATCC 12228 strain (GenBank accession number, AE015929) available in PubMed (http://www.ncbi.nlm.nih.gov) were also included for comparison purposes.
Screening for resistance determinants
Since elevated MICs of clindamycin, erythromycin and quinupristin/dalfopristin were observed for some of the S. epidermidis strains, these were screened by PCR for MLS resistance determinants [23S rRNA target-site modification (erm)-, efflux pump-and modifying enzyme-encoding genes] previously reported in staphylococci. 18 Primers utilized in these reactions are listed in Table 1 . Strains previously characterized were used as positive controls and presumable positive PCR products were confirmed by sequencing.
Molecular typing
PFGE of SmaI digests was performed to investigate clonality, and pattern analysis was carried out using the GelCompar II software (Applied Math, Kortrijk, Belgium). 23 Percentage similarities were identified on a dendrogram derived from the unweighted pair group method using arithmetic averages and based on Dice coefficients. Band position tolerance and optimization were set at 1.2% and 0.5%, respectively. Isolates showing a similarity coefficient of ≥80% were considered to be genetically related. The cfr-carrying isolate was further characterized by multilocus sequence typing (MLST) as described elsewhere. 24 
DNA plasmid profile, cfr location and curing experiment
Plasmid DNA was extracted from representative isolates belonging to each PFGE subtype using the Plasmid DNA Mini Kit (Qiagen GmbH, Hilden, Germany) and separated on 1% agarose gel. Plasmid sizes were determined using plasmid bands from Escherichia coli NCTC 50192 and 50193 as standard references. Plasmid DNA bands were transferred onto a nylon membrane by Southern blot. 25 cfr-specific labelled probe was generated and membrane hybridized using the non-radioactive DIG High Prime DNA labelling and Detection Kit (Roche Diagnostics GmbH, Mannheim, Germany). The cfr-carrying strain was submitted to plasmid-DNA-curing experiments as previously described. 26 
Results
Antimicrobial susceptibility testing
The clinical isolates included in this investigation demonstrated decreased susceptibility to linezolid (MICs, 4 -8 mg/L), except for S. epidermidis 4303A, for which the MIC was markedly elevated (64 mg/L; Table 2 ). These strains were resistant to ciprofloxacin, clindamycin, erythromycin, gentamicin and chloramphenicol, while being susceptible to vancomycin (MICs, 2 mg/L), daptomycin (MICs, 0.25-0.5 mg/L), tigecycline (MICs, 0.12-0.25 mg/L) and tetracycline (isolate 5174A was tetracycline resistant based on EUCAST criteria). Most isolates were also susceptible to quinupristin/dalfopristin, except for strains 5174A (MIC, 2 mg/L; intermediate) and 4303A (8 mg/L; resistant). Only S. epidermidis 12375A was methicillin (oxacillin) susceptible. MICs of retapamulin for most S. epidermidis were ≤0.5 mg/L, except for 12382A (MIC, 1 mg/L) and 4303A (MIC, 256 mg/L), which were considered intermediate and resistant, respectively. 22 Variable susceptibility results for trimethoprim/sulfamethoxazole were noted. For the plasmid-cured S. epidermidis strain (4303Ac) linezolid, quinupristin/dalfopristin and retapamulin MICs were lower than for the index cfr-carrying strain (4303A), while similar MICs of other tested compounds were observed. In addition, the cured strain exhibited a linezolid MIC (4 mg/L) similar to those for the cfr-negative strains (4 -8 mg/L).
Ribosomal target site mutations and resistance determinants
Clinical S. epidermidis isolates, including the linezolid-susceptible control strain (5204A), demonstrated L3 Leu101Val mutations (Table 2 ). All isolates with elevated linezolid MICs also exhibited Phe147Leu and Ala157Arg modifications when compared with the control L3 amino acid sequences (strains 5204A and ATCC 12228). All investigated isolates displaying linezolid MICs of ≥4 mg/L had L4 Asn158Ser. In addition, S. epidermidis 12375A possessed a Lys68Arg alteration in L4. Mutations in the 23S rRNA or L22 were not detected. All isolates carried erm(A) and msr(A) ( Table 2 ). Several strains harboured the vga(A) gene, which demonstrated a protein with highest identity to those sequences under accession numbers ADA62827 (100.0% identity), ACX34100 (99.8%), AAF24091 (99.6%), AAA26684 (99.6%) 27 and ACJ55987 (98.9%). 21 S. epidermidis 4303A was PCR positive for cfr and lsa(B), whereas these genes were not PCR amplified when using 4303Ac as template. Furthermore, the lsa(B)-encoded protein detected in 4303A showed greatest identity to that under the GenBank accession number AM408573. Additional MLS resistance genes investigated were not detected.
Molecular typing, DNA plasmid profile and cfr location
The PFGE results showed that the isolates belonged to a single clone (four subtypes; coefficient of similarity ≥86.4%; Figure 1 and Table 2 ) and the cfr-positive strain was associated with sequence type (ST)-23. Plasmid analysis showed several plasmid bands ranging from 1.5 to 66 kb in size. Following Southern blot and hybridization with a cfr probe, a signal was noted on a band of 66 kb from isolate 4303A (data not shown). Notably, this 66 kb plasmid band was not observed in the plasmid-cured cfr strain 4303Ac.
Discussion
The cfr-negative S. epidermidis bacteraemic isolates displayed elevated linezolid MICs (4 -8 mg/L) and the L3 and L4 ribosomal proteins demonstrated the presence of amino acid alterations. L3 Leu101Val was also observed in the linezolid-susceptible strain, suggesting that this modification may be considered as a clonal marker rather than a resistance-defining mutation. However, DHis146 and Gly155Arg in L3 have previously been observed in laboratory-derived S. aureus mutants for which linezolid MICs were 4-8 mg/L. 4 These modifications are close to Phe147Leu and Ala157Arg observed in this study. Given the proximity of these alterations to the linezolid-binding site (peptidyl transferase centre), the drug target affinity may be compromised, as previously described by Locke et al. 4 Mutations within a conserved region of the L4 protein ( 63 KPWRQKGTGRAR 74 ) have been associated with cross-resistance to macrolides, linezolid or chloramphenicol in Streptococcus pneumoniae, S. aureus and Clostridium perfringens. 4, 28, 29 In contrast, the L4 Asn158Ser alteration, also detected in this study, has been previously described in linezolid-susceptible S. epidermidis. Therefore, alterations at Asn158 probably do not confer linezolid resistance. Isolate 12375A possessed an additional mutation (Lys68Arg) within the conserved L4 region. Although modifications in this region have been implicated in drug resistance, Lys68Arg did not appear to affect the elevated linezolid and chloramphenicol MICs, since 12375A exhibited similar results for these drugs compared with other strains (Table 2) . Table 2 . Mendes et al.
MICs of retapamulin for cfr-negative strains were higher (0.25 -1 mg/L) than for the ATCC 12228 and 5204A strains (≤0.06 mg/L). In addition, retapamulin MIC results seemed to correlate with the presence of vga(A), since S. epidermidis possessing this gene showed retapamulin MICs (0.5-1 mg/L) slightly higher (2-to 4-fold) than those for vga(A)-negative strains (0.25 mg/L). Similar results were noted for quinupristin/ dalfopristin, where vga-positive isolates demonstrated MIC values of 1 -2 mg/L, while vga-negative strains had streptogramin combination MIC values of ≤0.5 mg/L. Pleuromutilin resistance has been associated with several L3 mutations, including Ala157 observed in this investigation. 30 -32 Furthermore, vga genes may confer resistance to pleuromutilins in addition to streptogramin A-like compounds and lincosamides. 33 Therefore, the decreased retapamulin susceptibility observed among cfr-negative isolates may have been secondary to amino acid substitutions in L3 coupled with vga(A).
Notably, the Vga(A) observed among the studied isolates showed greatest similarity to the previously reported proteins ADA62827, ACX34100, AAF24091, AAA26684 27 and ACJ55987. 17 While staphylococcal isolates producing the former were not tested against pleuromutilins, the strain producing Vga(A) under the accession number ACJ55987 conferred high-level resistance (MIC, 64 mg/L). 21 The Vga(A) ACJ55987 protein possesses six amino acid mutations compared with Vga(A) described in this study. Four of these alterations are located in a central region between two ATP-binding domains. It is tempting to propose that the low-level (2-to 4-fold) pleuromutilin resistance observed among Vga(A)-producing strains in this study was due to a lower specificity for this drug or lower transcription levels (i.e. chromosomal location).
S. epidermidis 4303A was PCR positive for cfr, which explains the observed elevated MICs of linezolid (64 mg/L), quinupristin/ dalfopristin (8 mg/L) and retapamulin (256 mg/L). MICs of these drugs decreased once the cfr-carrying plasmid was removed and the 4303Ac cured strain displayed an antimicrobial susceptibility profile most similar to the cfr-negative S. epidermidis included in this study. Moreover, cfr and lsa(B) were detected in S. epidermidis 4303A, but not in the plasmid-cured strain, suggesting that these genes were embedded in the same plasmid, as also previously reported. 34 However, this observation requires further confirmation.
The S. epidermidis included in this study were recovered over a 2 year period in patients from several hospital services. In addition, strains belonging to different subtypes (e.g. 12417A and 12421A) were collected on the same day, indicating co-existence of subtypes. These data may suggest that these strains belong to an endemic clone that has been established in this institution, rather than being part of an ongoing outbreak. This has been reported in previous studies, which demonstrated that a significant proportion of S. epidermidis may become endemic over long periods. 35, 36 Furthermore, a recent MLST analysis of a collection of S. epidermidis from various origins revealed a high degree of genetic diversity, but also identified nine epidemic clonal lineages disseminated worldwide. Among those, ST-2 was the most widely disseminated, while ST-23 was the second most often disease-associated ST. 24 In summary, the findings observed in this investigation highlight the ability of S. epidermidis to accumulate antimicrobial resistance phenotypes through target site mutations or acquisition of multidrug resistance genes. cfr remains rare among staphylococci recovered from human clinical specimens; 2, 3 however, due to the genome versatility 37 and tendency for clonal dissemination of CoNS, 11, 35, 36 cfr-carrying isolates may become a serious threat to several potent Gram-positive-active agents. 
